Portfolio - Asabys Partners

Portfolio

February 16, 2022

SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline

READ THIS NEWS IN SPANISH Financing co-led by UCB Ventures and Ysios Capital with participation…

Mark

Portfolio

December 15, 2021

Agomab Therapeutics Completes Acquisition of Origo Biopharma

Agomab Therapeutics NV (‘Agomab’) announced today the closing of the Origo Biopharma acquisition. The transaction,…

Mark

Portfolio

January 4, 2022

“Cara Care for IBS” approved as a prescription digital therapeutic – German health insurances will reimburse the costs with a medical prescription for 90% of Germans

(Berlin, 03.01.22) Cara Care for IBS, the first prescription digital therapeutic for irritable bowel syndrome…

Mark

Portfolio

December 2, 2021

ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors

Seasoned biotech executive with a wealth of experience and a track-record of strategic alliances in…

Mark

Portfolio

October 28, 2021

Agomab Therapeutics to Acquire Origo Biopharma

READ THIS NEWS IN SPANISH Acquisition strengthens Agomab as a leader in targeting growth factor…

Mark

Portfolio

October 21, 2021

ONA Therapeutics Strengthens Scientific Leadership Team

Industry veteran in oncology antibody discovery & development Dr Haijun Sun appointed Chief Scientific Officer…

Mark 0

Portfolio

October 6, 2021

Anaconda Biomed to close a venture debt of up to 10M€ by the EIB to treat acute ischemic stroke (AIS)

EIB to provide venture debt funding of up to €10 million to support the development…

Mark 1

Portfolio

September 28, 2021

Nuage Therapeutics, the spin-off from IRB Barcelona and ICREA, is launched with the support of Asabys

READ THIS NEWS IN SPANISH Nuage Therapeutics is a spin-off of IRB Barcelona and ICREA…

Mark

Portfolio

July 8, 2021

Merck and INBRAIN Neuroelectronics Collaborate to Develop the Next Generation of Bioelectronic Therapies

READ THIS NEWS IN SPANISH Innovation Center project of Merck collaborates to develop smart neuro-modulation…

Mark 0

Portfolio

March 26, 2021

INBRAIN Neuroelectronics raises over €14M Series A led by Asabys Partners, Alta Life Sciences and CDTI to develop intelligent graphene-based neuroelectronic therapies for brain related disorders

READ THIS NEWS IN SPANISH Barcelona, March 26th, 2021 INBRAIN Neuroelectronics is a spin-off company…

admin

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others